• Home
  • About Us | Snoasis Medical
Snoasis Medical
Snoasis Medical


About Us
PIONEERING PLACENTA TISSUE SCIENCE AND REGENERATIVE BIOMATERIAL
Snoasis Medical has pioneered the development and use of placental tissue products for tissue repair and regeneration in dental-oral maxillofacial surgery. Over the past decade, the Company has become the industry leader in placental tissue products, not only in terms of sales and market share, but in technical expertise and the development of clinical and scientific data. Through these efforts, Snoasis Medical created this class of dental membrane product.

Snoasis Medical was founded by Robert Tofe in 2007 after he began researching the concept of placental tissue in dental-oral maxillofacial surgery. In 2008, Snoasis Medical partnered with a placental tissue processor currently known as MiMedx Group. Together, the two companies developed the intellectual property portfolio, which is used to process BioXclude, along with other future amniotic tissue product configurations.

Today, Snoasis Medical operates by its Vision: To become the number one dental regenerative products company in the United States and to share the benefits of its placental tissue products with the rest of the world.


ROBERT TOFE Founder

About Us
Snoasis Medical has pioneered the development and use of placental tissue products for tissue repair and regeneration in dental-oral maxillofacial surgery. Over the past decade, the Company has become the industry leader in placental tissue products, not only in terms of sales and market share, but in technical expertise and the development of clinical and scientific data. Through these efforts, Snoasis Medical created this class of dental membrane product.

ROBERT TOFE
Founder

Snoasis Medical was founded by Robert Tofe in 2007 after he began researching the concept of placental tissue in dental-oral maxillofacial surgery. In 2008, Snoasis Medical partnered with a placental tissue processor currently known as MiMedx Group. Together, the two companies developed the intellectual property portfolio, which is used to process BioXclude, along with other future amniotic tissue product configurations.

Today, Snoasis Medical operates by its Vision: To become the number one dental regenerative products company in the United States and to share the benefits of its placental tissue products with the rest of the world.



Our Core Values

Honesty
Hard Work
Having Fun (2x)
Sharing Success
Continual Learning
Being a Great Partner
Love Good Science and Research


Our Team

RANDY LOOPER
President
ERIC FRANK
Vice President
Of Finance
DENNIS VIALPANDO
Vice President of Regulatory & Quality Systems
PETE MARINER
Chief Scientific
Officer
MATTHEW BURNS
Director of Business
Development
TIANNAH HALCOMB
Director of
Key Accounts
CONNER CAMPBELL
Account
Manager
BRIDGETTE MCKEE
Customer
Service Lead
SYLENA MANES
Customer
Service
MICHELLE CHRISTMANN
Customer Service
and Accounting
ALEXIS VIALPANDO
Customer
Service
NICHOLE STROLE
Operations
Technician
Our Vision

To become the number one dental regenerative products company in North America and share the benefits of our technology and products with the rest of the world.


Our Mission Statements

(1) We strive to provide solutions to the unmet needs of dental-oral maxillofacial surgery for tissue repair and regeneration,

(2) We respect that many of our customers own and operate small businesses, that most procedures are not covered by reimbursement, and that the cost of materials directly impacts their bottom line,

(3) We utilize information technology across all areas of our business to enable us to be a better partner to our customers, reduce operating costs, increase productivity, and document the clinical benefits provided by our regenerative products,

(4) We are dedicated to offering new and innovative regenerative products at a reasonable price, and

(5) We are focused on growing our revenue to provide for Snoasis Medical employees, support corporate growth, invest in key areas of the business to build a long term sustainable competitive advantage, and deliver a great return to our shareholders.